Utility of targeted, amplicon-based deep sequencing to detect resistance to first-line tuberculosis drugs in Botswana

You are here: Home / Initiative Publications / Utility of targeted, amplicon-based deep sequencing to detect resistance to first-line tuberculosis drugs in Botswana